INTERNATIONAL PATENT: ABBOTT LABORATORIES FILES APPLICATION FOR "METHODS OF DETERIMING AND PREDICTING THE EFFECTIVENESS OF IMMUNE CHECKPOINT INHIBITOR TREATMENT IN SUBJECTS WITH HEPATOCELLULAR CARCINOMA"

GENEVA, Jan. 13 -- ABBOTT LABORATORIES (100 Abbott Park RoadAbbott Park, Illinois 60064) filed a patent application (PCT/US2025/036000) for "METHODS OF DETERIMING AND PREDICTING THE EFFECTIVENESS OF IMMUNE CHECKPOINT INHIBITOR TREATMENT IN SUBJECTS WITH HEPATOCELLULAR CARCINOMA" on Jul 01, 2025. With publication no. WO/2026/010899, the details related to the patent application was published on Jan 08, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): YAMASHITA, Taro (c/o Kanazawa UniversityKakumamachi, IshikaKanazawa, Ishikawa 920-1192), OKADA, Hikari (c/o Kanazawa UniversityKakumamachi, Ishik...